The Stanford Headache Program Clinical Trials

Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
PI: Meredith Barad, MD
NCT02168764
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

Sunstar: The Stanford Neuroscience Headache Biorepository
PI: Robert Cowan, MD, FAAN
NCT03231241
Study Status: Enrolling
Research Coordinator: Bharati Sanjanwala
Contact: bharatis@stanford.edu

Diagnostic comparison of an online questionnaire versus  a semi-structured interview for the diagnosis of primary headache disorders, using ICHD 3 as the Gold Standard
PI: Robert Cowan, MD, FAAN
NCT03304886
Study Status: Closed to Enrollment
Research Coordinator: Bharati Sanjanwala
Contact: bharatis@stanford.edu

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Evaluate the Efficacy, Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants with Episodic Migraine (ADVANCE)
PI: Nada Hindiyeh, MD
NCT03777059
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens (Intravenous/Subcutaneous and Subcutaneous) of TEV-48125 Versus Placebo for the Prevention of Epidosic Cluster Headache
PI: Nada Hindiyeh, MD
NCT02945046
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens (Intravenous/Subcutaneous and Subcutaneous) of TEV-48125 Versus Placebo for the Prevention of Chronic Cluster Headache
PI: Nada Hindiyeh, MD
NCT02964338
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Multicenter, Double-Blind, Double-Dummy Study to Explore the Long-Term Safety of TEV-48125 for the Prevention of Cluster Headache
PI: Nada Hindiyeh, MD
NCT03107052
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Randomized, Multicenter, Double-Blind, Parallel, Sham-Controlled Study of Non-Invasive Vagus Nerve Stimulation (NVNS) for the Prevention of Migraines. (PREMIUM II)
PI: Nada Hindiyeh, MD
NCT03716505
Study Status: Enrolling
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Phase 3b Multicenter, SIngle-arm, Open-label Safety Study of Ly2951742 (Galcanezumab) in Patients with Episodic or Chronic Cluster Headache
PI: Nada Hindiyeh, MD
NCT02797951
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headache
PI: Nada Hindiyeh, MD
NCT02397473
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache
PI: Nada Hindiyeh, MD
NCT02438826
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A 12-Month Prospective, Randomized, Interventional, Global, Multi-Center, Active-Controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (Erenumab GM vs. Oral Prophylactics) in Adult Episodic Migraine Patients (CAMG334A2401)
PI: Nada Hindiyeh, MD
NCT03927144
Study Status: Enrolling
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
PI: Nada Hindiyeh, MD
NCT03901482
Study Status: Enrolling
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Parallel Group Double-Blind Randomized PlaceboControlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing an Acute Attack of Migraine
PI: Nada Hindiyeh, MD
NCT04152083
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

Randomized, Double-Blind, Multi-Center, Parallel-Group Comparison of the Efficacy and Safety of the C213 (Zolmitriptan Microneedle System) to Placebo for the Acute Treatment of Cluster Headaches
PI: Nada Hindiyeh, MD
NCT04066023
Study Status: Enrolling
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A PHASE 3, MULTICENTER, OPEN-LABEL 40-WEEK EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ORAL ATOGEPANT FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH EPISODIC MIGRAINE
PI: Nada Hindiyeh, MD
NCT03777059
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

A Long-Term, Open-Label Safety Study to Evaluate the Safety of M207 (Intracutaneous Microneedle System) in the Acute Treatment of Migraine
PI: Nada Hindiyeh, MD
NCT03282227
Study Status: Closed to Enrollment
Research Coordinator: Stephanie Tran
Contact: trans@stanford.edu

For more information on our clinical trials

Maria Coburn
Clinical Research Manager
mcoburn@stanford.edu

(650) 736-9551